Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patch ECG-based REcurrEnce Monitoring After Catheter Ablation in PaTients with Atrial Fibrillation (PREEMPT-AF) : a Multicenter, Randomized Controlled, Open-label, Prospective Trial

NCT06751459 is registered in ClinicalTrials.gov with HUINNO Co., Ltd as lead sponsor.

NCT NCT06751459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06751459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patch ECG-based REcurrEnce Monitoring After Catheter Ablation in PaTients with Atrial Fibrillation (PREEMPT-AF) : a Multicenter, Randomized Controlled, Open-label, Prospective Trial
Lead sponsor
HUINNO Co., Ltd
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 6, 2025
Completion date
March 1, 2027
Enrollment
270 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af)